ABSTRACT
OBJECTIVE: To evaluate the contribution that unilateral thoracic sympathectomy in dominant side or two-stage bilateral thoracic sympathectomy can have as strategies to reduce the incidence of compensatory sweating after sympathectomy for palmar hyperhidrosis. METHODS: This is a prospective, controlled, randomized multicenter trial of 200 participants with palmar hyperhidrosis, which will be randomized into two arms: (a) one-stage bilateral thoracic sympathectomy (control arm); or (b) unilateral thoracic sympathectomy in dominant side (intervention arm). At six months the participants submitted to unilateral procedure can make the contralateral surgery if they wanted it, creating a third group called two-stage bilateral sympathectomy. Participants will be evaluated for the degree of sweating by the Hyperhidrosis Disease Severity Scale (HDSS) and of quality of life questionnaires. RESULTS: 96 participants out of the 200 proposed have been included so far, with 48 participants randomized to each arm. From the sample 61 (63.5%) are female, with a mean age of 24 (20-32) years. There were exclusive palmar hiperhydrosis in 14 cases (14.5%), palmar and plantar hyperhidrosis in 36 (37.5%) cases, palmar and axillar hyperhidrosis in 12 (12,5%) cases and palmar-axillary-plantar hyperhidrosis in 34 (35,4%) cases. The age at the beginning of the disease was childhood (78%), with mean of time of disease 15 (11-22) years. CONCLUSIONS: If one or both hypothesis: (a) unilateral sympathectomy in dominant hand is a satisfactory treatment; b) two-stage bilateral sympathectomy causes less compensatory sweating than in one stage are confirmed there is a chance that surgical therapy for palmar hyperhidrosis can be changed for better.
ABSTRACT
Over one million cases of the SARS-CoV-2 virus have been confirmed worldwide, with the death toll exceeding 50,000 people. An important issue to be addressed concerns the exposure of health professionals to this new virus. The first reports from Wuhan province, China, described infection rates of up to 29% among healthcare professionals before the use of personal protective equipment (PPE) was fully regulated. There are several protocols on the correct use of PPE during aerosol-generating procedures. However, there is no specific guidance on how to proceed in cases of need for chest tubes in patients with positive COVID-19 active air leak. The objective of this work is to assist surgeons of the most diverse specialties during the chest drainage of a patient with COVID-19 and to avoid a risk of contamination to the professional and the environment.
Subject(s)
Coronavirus Infections/prevention & control , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Pandemics/prevention & control , Personal Protective Equipment , Pneumonia, Viral/prevention & control , Thoracentesis/instrumentation , COVID-19 , Coronavirus Infections/surgery , Humans , Pneumonia, Viral/surgery , Practice Guidelines as Topic , Thoracentesis/standardsABSTRACT
Mais de um milhão de casos do vírus SARS-CoV-2 foram confirmados em todo o mundo, com o número de mortos ultrapassando 50.000 pessoas. Uma questão importante a ser abordada diz respeito à exposição dos profissionais de saúde à esse novo vírus. Os primeiros relatórios da província de Wuhan, na China, descreveram taxas de infecção de até 29% entre os profissionais de saúde antes que o uso de equipamentos de proteção pessoal (EPI) fosse totalmente regulamentado. Existem vários protocolos sobre o uso correto de EPI durante os procedimentos geradores de aerossóis. No entanto, não há orientação específica sobre como proceder em casos de necessidade de drenos torácicos em pacientes com vazamento de ar ativo COVID-19 positivos. O objetivo desse trabalho é auxiliar os cirurgiões das mais diversas especialidades durante a drenagem torácica de um paciente com COVID-19 e evitar um risco de contaminação ao profissional e no ambiente.
ABSTRACT
Over one million cases of the SARS-CoV-2 virus have been confirmed worldwide, with the death toll exceeding 50,000 people. An important issue to be addressed concerns the exposure of health professionals to this new virus. The first reports from Wuhan province, China, described infection rates of up to 29% among healthcare professionals before the use of personal protective equipment (PPE) was fully regulated. There are several protocols on the correct use of PPE during aerosol-generating procedures. However, there is no specific guidance on how to proceed in cases of need for chest tubes in patients with positive COVID-19 active air leak. The objective of this work is to assist surgeons of the most diverse specialties during the chest drainage of a patient with COVID-19 and to avoid a risk of contamination to the professional and the environment.
ABSTRACT
ABSTRACT Over one million cases of the SARS-CoV-2 virus have been confirmed worldwide, with the death toll exceeding 50,000 people. An important issue to be addressed concerns the exposure of health professionals to this new virus. The first reports from Wuhan province, China, described infection rates of up to 29% among healthcare professionals before the use of personal protective equipment (PPE) was fully regulated. There are several protocols on the correct use of PPE during aerosol-generating procedures. However, there is no specific guidance on how to proceed in cases of need for chest tubes in patients with positive COVID-19 active air leak. The objective of this work is to assist surgeons of the most diverse specialties during the chest drainage of a patient with COVID-19 and to avoid a risk of contamination to the professional and the environment.
RESUMO Mais de um milhão de casos do vírus SARS-CoV-2 foram confirmados em todo o mundo, com o número de mortos ultrapassando 50.000 pessoas. Uma questão importante a ser abordada diz respeito à exposição dos profissionais de saúde à esse novo vírus. Os primeiros relatórios da província de Wuhan, na China, descreveram taxas de infecção de até 29% entre os profissionais de saúde antes que o uso de equipamentos de proteção pessoal (EPI) fosse totalmente regulamentado. Existem vários protocolos sobre o uso correto de EPI durante os procedimentos geradores de aerossóis. No entanto, não há orientação específica sobre como proceder em casos de necessidade de drenos torácicos em pacientes com vazamento de ar ativo COVID-19 positivos. O objetivo desse trabalho é auxiliar os cirurgiões das mais diversas especialidades durante a drenagem torácica de um paciente com COVID-19 e evitar um risco de contaminação ao profissional e no ambiente.
